During 35+ years of clinical use and more than 1,700 implants worldwide, the SynCardia temporary Total Artificial Heart (TAH) has been used in patients with a variety of pre-implant etiologies that have contributed to irreversible biventricular failure. For more information about which patients should be considered for the SynCardia TAH, visit our Patient Selection page or download our Patient Selection Guide.
Idiopathic Dilated Cardiomyopathy
Congenital and Genetic Conditions
Post-Heart Transplant Graft Failure
LVAD Failures (Device Malfunction or RV Failure)
Source: As reported on SynCardia Implant Forms and in published scientific papers as of 15 Dec 2017. Not all Implant Forms have complete information.
*Note: Some patients have multiple pre-implant etiologies and are counted as a case under more than one category.
Several patients have been supported by the TAH for more than 4.5 years.
Source: As reported on SynCardia Implant Forms and Explant Forms as of 9 Oct 2017. Not all Implant Forms have complete information.
Profile 1: Critical cardiogenic shock
Profile 2: Progressive decline
Profile 3: Stable but inotrope dependent
Profile 4: Resting symptoms
Profile 5: Exertion intolerant
Profile 6: Exertion limited
Profile 7: Advanced NYHA Class 3
Source: INTERMACS Quarterly Statistical Report for SynCardia Systems, Inc. 2017 Q3